25 January 2016Immunocore’s IMCgp100 Granted Orphan Drug Designation by US FDA for the Treatment of Uveal Melanoma
25 January 2016Immunocore’s IMCgp100 Granted Orphan Drug Designation by US FDA for the Treatment of Uveal Melanoma
21 January 2016
PepTalk
21st - 22nd January 2016
San Diego, US
20 January 2016Immunocore Starts Clinical Trial with IMCgp100 in Combination with MedImmune Immunotherapies Durvalumab and Tremelimumab
11 January 2016
JP Morgan 34th Annual Healthcare Conference
Available for Business Development & Investor Relations Meetings
11th to 15th January 2016
San Francisco, US
06 January 2016Immunocore and GlaxoSmithKline Select First ImmTAC Clinical Candidate in Discovery Collaboration
10 December 2015
Genesis 2015
10th December 2015
London, UK
07 December 2015
IBC's 26th Annual Antibody Engineering and Therapeutics
7th to 10th December 2015
San Diego, US
03 December 2015Immunocore wins Biotech of the Year at the SCRIP Awards 2015
20 November 2015
ESMO Symposium on Immuno-Oncology
20th to 21st November 2015
Geneva, Switzerland